Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
Grant
Adjust height of sidebar
KMap
Grant
A Phase 2, Randomized, Double-blinded, Placebo-controlled, Parallel Group Study Evaluating the Efficacy and Safety of Amiselimod (Mt-1303) in Subjects With Mild to Moderate Ulcerative Colitis (UC)
Sponsored by Salix Pharmaceuticals, Incorporated
Active
$240.8K Funding
3 People
External
Related Topics
pharmacology,
gastroenterology,
clinical trials,
immunology,
drug safety
People
Kirsten Anderson
(CD)
Senior VP Health Sciences
﹒Research Compliance Administrator IV
Sasha Taleban
Principal Investigator (PI)
Medicine
﹒Associate Professor
Maria Gordon
(CD)
Senior VP Health Sciences
﹒Clinical Research Manager II